Skip to content

PTC Therapeutics PTCT Market capitalization

Market capitalization at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$10.86B-19.4%
ALN
Alnylam PharmaceuticalsALNY
$43.88B+25.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%
Arrowhead Research logo
Arrowhead ResearchARWR
$8.78B+402%
United Therapeutics logo
United TherapeuticsUTHR
$25.99B+87.7%
Biogen logo
BiogenBIIB
$26.91B+34.3%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Computed from the period-end share price: $5.64B.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's market capitalization?
PTC Therapeutics (PTCT) reported market capitalization of $5.64B in Q1 2026.
How has PTC Therapeutics's market capitalization changed year-over-year?
PTC Therapeutics's market capitalization increased by 40.3% year-over-year, from $4.02B to $5.64B.
What is the long-term trend for PTC Therapeutics's market capitalization?
Over 5 years (2020 to 2025), PTC Therapeutics's market capitalization has grown at a 7.2% compound annual growth rate (CAGR), from $4.31B to $6.1B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.